EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Recent Progress in Antimicrobial Peptides (AMPs) Towards Enhanced Selectivity and Reduced Cytotoxicity by Molecular Engineering

Silvi Gautam iD, Shagun Gautam iD, Jahanvi Saini iD, Indu Singh, Divakar Sharma iD, Divya Venugopal iD

Biotechnology and Bioengineering · 2026

DOI: 10.1002/bit.70286 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biotechnology and Bioengineering, 2026. Verfasst von Silvi Gautam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, India. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Protein Engineering, Anti-Infective Agents, Antimicrobial Cationic Peptides. Die Arbeit nennt 124 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increased prevalence of antimicrobial resistance has led to the urgent need for designing and developing new therapeutic alternatives to conventional antibiotics. Antimicrobial peptides (AMPs) represent a promising class of antimicrobial agents, with broad‐spectrum activity and rapid action, and a low potential to promote antibiotic resistance. This review article synthesizes progress in engineering AMPs to optimize effectiveness in terms of enhancing selectivity for treating infections while minimizing cytotoxicity to host cells. Mechanisms by which AMPs exert their effects, such as disrupting membranes, targeting intracellular portions of the cell, inhibiting biofilm formation, and modulating immune response, will be explored in relation to interactions between AMPs and lipid bilayers. The effects of physicochemical properties (e.g., charge and hydrophobicity), peptide length (number of amino acids), and peptide secondary structure on antimicrobial activity and host compatibility are outlined. An overview will be provided of some of the new design approaches for engineering peptides, including peptide modifications, peptide mimetic structures, hybrid peptides, dendritic AMPs, and the use of computational methods and bioengineering techniques. This review highlights current challenges for AMPs, including stability, toxicity, delivery, and drug development for clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial PeptidesProtein EngineeringAnti-Infective AgentsAntimicrobial Cationic PeptidesHumansAnimals

Stichwörter der Autor:innen

antimicrobial peptides (AMPs)antimicrobial resistance (AMR)challengescytotoxicityengineering

Substanzen

Antimicrobial PeptidesAnti-Infective AgentsAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Department of Microbiology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, India.
  • School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
  • School of Pharmacy, Graphic Era Hill University, Dehradun, Uttarakhand, India.
  • Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, India.

ORCID-Profile: Silvi Gautam, Shagun Gautam, Jahanvi Saini, Divakar Sharma, Divya Venugopal

Zitieren

APA

Gautam, S., Gautam, S., Saini, J., Singh, I., Sharma, D., & Venugopal, D. (2026). Recent Progress in Antimicrobial Peptides (AMPs) Towards Enhanced Selectivity and Reduced Cytotoxicity by Molecular Engineering. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70286

Vancouver

Gautam S, Gautam S, Saini J, Singh I, Sharma D, Venugopal D. Recent Progress in Antimicrobial Peptides (AMPs) Towards Enhanced Selectivity and Reduced Cytotoxicity by Molecular Engineering. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70286

BibTeX
@article{Gautam2026,
  author = {Gautam, Silvi and Gautam, Shagun and Saini, Jahanvi and Singh, Indu and Sharma, Divakar and Venugopal, Divya},
  title = {Recent Progress in Antimicrobial Peptides (AMPs) Towards Enhanced Selectivity and Reduced Cytotoxicity by Molecular Engineering},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70286}
}
Kostenlos starten →